{"id":"NCT02493764","sponsor":"Merck Sharp & Dohme LLC","briefTitle":"Imipenem/Relebactam/Cilastatin Versus Piperacillin/Tazobactam for Treatment of Participants With Bacterial Pneumonia (MK-7655A-014)","officialTitle":"A Phase III, Randomized, Double-Blind, Active Comparator-Controlled Clinical Trial to Study the Safety, Tolerability, and Efficacy of Imipenem/Cilastatin/Relebactam (MK-7655A) Versus Piperacillin/Tazobactam in Subjects With Hospital-Acquired Bacterial Pneumonia or Ventilator-Associated Bacterial Pneumonia","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2015-11-24","primaryCompletion":"2019-04-03","completion":"2019-04-03","firstPosted":"2015-07-09","resultsPosted":"2020-04-16","lastUpdate":"2020-04-16"},"enrollment":537,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Bacterial Pneumonia"],"interventions":[{"type":"DRUG","name":"Imipenem","otherNames":[]},{"type":"DRUG","name":"Relebactam","otherNames":[]},{"type":"DRUG","name":"Cilastatin","otherNames":[]},{"type":"DRUG","name":"Piperacillin","otherNames":[]},{"type":"DRUG","name":"Tazobactam","otherNames":[]},{"type":"DRUG","name":"Linezolid","otherNames":[]}],"arms":[{"label":"IMI/REL","type":"EXPERIMENTAL"},{"label":"PIP/TAZ","type":"ACTIVE_COMPARATOR"}],"summary":"This study aims to compare treatment with a fixed-dose combination (FDC) of imipenem/relebactam/cilastatin (IMI/REL) with a FDC of piperacillin/tazobactam (PIP/TAZ) in participants with hospital-acquired or ventilator-associated bacterial pneumonia (HABP or VAPB, respectively). The primary hypothesis is that IMI/REL is non-inferior to PIP/TAZ in the incidence rate of all-cause mortality.","primaryOutcome":{"measure":"Percentage of Participants With All-cause Mortality (ACM) Through Day 28 in the Modified Intention-to-treat (MITT) Population","timeFrame":"Up to 28 days","effectByArm":[{"arm":"IMI/REL","deltaMin":15.9,"sd":null},{"arm":"PIP/TAZ","deltaMin":21.3,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":6,"exclusionCount":16},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":["37383243","34704389","32785589"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":71,"n":266},"commonTop":["Anaemia","Diarrhoea","Aspartate aminotransferase increased","Hypokalaemia","Alanine aminotransferase increased"]}}